Preoperative use of enoxaparin and tirofiban: possible association with increased bleeding postbypass.
Skubas
N J
NJ
Department of Anesthesiology, Washington University School of Medicine, and Barnes-Jewish Hospital, Saint Louis, Missouri, USA. skubasn@notes.wustl.edu
Despotis
G J
GJ
Vlasnic
J J
JJ
Moon
M R
MR
D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects*; D000933:Antifibrinolytic Agents / Q000009:adverse effects*; D001026:Coronary Artery Bypass / Q000009:adverse effects*; D017984:Enoxaparin / Q000009:adverse effects*; D006801:Humans; D008297:Male; D019106:Postoperative Hemorrhage / Q000139:chemically induced*; D000077466:Tirofiban; D014443:Tyrosine / Q000009:adverse effects / Q000031:analogs & derivatives*
D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D017984:Enoxaparin; D014443:Tyrosine; D000077466:Tirofiban